Accuray

Accuray Incorporated is a global leader in radiation oncology, focusing on advanced radiation therapy systems for cancer treatment. Founded in 1990 and headquartered in Madison, Wisconsin, the company is publicly traded on Nasdaq under the symbol ARAY. Accuray is dedicated to delivering precise, patient-first radiation therapies that aim to reduce suffering and improve clinical outcomes. The company develops and manufactures innovative platforms, including the CyberKnife and TomoTherapy/Radixact systems. These technologies enable stereotactic radiosurgery and stereotactic body radiation therapy, targeting tumors with sub-millimeter accuracy while minimizing damage to surrounding healthy tissue. Accuray operates manufacturing facilities in multiple locations, including the United States, Switzerland, and China, and has installations in approximately 50 countries. The company collaborates with various partners to enhance treatment planning and workflow efficiency, emphasizing its commitment to improving accessibility to advanced radiation therapies worldwide.